UV2-27429-54464
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 985 / WA
- Registered
- 2021-06-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-01
Dose 1 — Pfizer-BioNTech
-
2021-06-22
Registered in v-safe
-
2021-06-22
Dose 2 — Pfizer-BioNTech
- 2021-06-22
-
2021-06-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-24
- 2021-06-25
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-07-06
- 2021-07-13
-
2021-07-20
Survey response — day 28, dose 2MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Cough and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-07-27
Survey response — day 35, dose 2MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Cold symptoms - cough and runny noseMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-03
- 2021-09-21
- 2021-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-01 | Pfizer-BioNTech | No |
| 2 | 2021-06-22 | Pfizer-BioNTech | No |
Free text
Release 9 — day 28, dose 2
Symptoms: Cough and runny nose
Release 9 — day 35, dose 2
Symptoms: Cold symptoms - cough and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release